A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins

Protein therapeutics have gained attention recently for treatment of a myriad of human diseases due to their high potency and unique mechanisms of action. We present the development of a novel polymeric thermosponge nanoparticle for efficient delivery of labile proteins using a solvent-free polymer thermo-expansion mechanism with clinical potential, capable of effectively delivering a range of therapeutic proteins in a sustained manner with no loss of bioactivity, with improved biological half-lives and efficacy in vivo.

[1]  F. Zhang,et al.  Discussion about several potential drawbacks of PEGylated therapeutic proteins. , 2014, Biological & pharmaceutical bulletin.

[2]  R. Langer,et al.  Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery , 2013, Science Translational Medicine.

[3]  E. Mathiowitz,et al.  Oral delivery of proteins by biodegradable nanoparticles. , 2013, Advanced drug delivery reviews.

[4]  N. Kamei,et al.  Noninvasive insulin delivery: the great potential of cell-penetrating peptides. , 2013, Therapeutic delivery.

[5]  Ira Tabas,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[6]  Robert H. Utama,et al.  Synthesis of hollow polymeric nanoparticles for protein delivery via inverse miniemulsion periphery RAFT polymerization. , 2012, Chemical communications.

[7]  P. Davies,et al.  Identification of potent small‐molecule inhibitors of STAT3 with anti‐inflammatory properties in RAW 264.7 macrophages , 2012, The FEBS journal.

[8]  Costas Kiparissides,et al.  Recent advances in nanocarrier-based mucosal delivery of biomolecules. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Seung Woo Chung,et al.  Strategies for non-invasive delivery of biologics , 2012, Journal of drug targeting.

[10]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[11]  Yaoli Song,et al.  Effects of PEGylation and Immune Complex Formation on the Pharmacokinetics and Biodistribution of Recombinant Interleukin 10 in Mice , 2012, Drug Metabolism and Disposition.

[12]  Young Ha Kim,et al.  Highly selective in-vivo imaging of tumor as an inflammation site by ROS detection using hydrocyanine-conjugated, functional nano-carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Dan Peer,et al.  Reshaping the future of nanopharmaceuticals: ad iudicium. , 2011, ACS nano.

[14]  S. Balu-Iyer,et al.  Delivery of therapeutic proteins. , 2010, Journal of pharmaceutical sciences.

[15]  Emmanuel Baslé,et al.  Protein chemical modification on endogenous amino acids. , 2010, Chemistry & biology.

[16]  Zhen Gu,et al.  A novel intracellular protein delivery platform based on single-protein nanocapsules. , 2010, Nature nanotechnology.

[17]  B. D. de Lumen,et al.  Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. , 2009, Biochemical and biophysical research communications.

[18]  J. Kreuter,et al.  Functional Protein Delivery into Neurons Using Polymeric Nanoparticles* , 2009, Journal of Biological Chemistry.

[19]  Qun Wang,et al.  Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. , 2009, Journal of biomedical nanotechnology.

[20]  T. Chou,et al.  Liquid perfluorochemical inhibits inducible nitric oxide synthase expression and nitric oxide formation in lipopolysaccharide-treated RAW 264.7 macrophages. , 2009, Journal of pharmacological sciences.

[21]  Young Ha Kim,et al.  One pot, single phase synthesis of thermo-sensitive nano-carriers by photo-crosslinking of a diacrylated pluronic , 2008 .

[22]  Young Ha Kim,et al.  Sustained release of human growth hormone from heparin-based hydrogel. , 2008, Biomacromolecules.

[23]  W. Saltzman,et al.  Bioengineering Approaches to Controlled Protein Delivery , 2008, Pediatric Research.

[24]  Malgorzata Smola,et al.  Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases , 2008, International journal of nanomedicine.

[25]  R. Peters,et al.  From fluorescence nanoscopy to nanoscopic medicine. , 2008, Nanomedicine.

[26]  B. Sarmento,et al.  Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles , 2007, International journal of nanomedicine.

[27]  Tao Wang,et al.  Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. , 2007, Colloids and surfaces. B, Biointerfaces.

[28]  K. Lundstrom,et al.  Review on Medusa®:a polymer-based sustained release technology for protein and peptide drugs , 2007, Expert opinion on drug delivery.

[29]  D. Edwards,et al.  Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity. , 2006, Experimental hematology.

[30]  S. Elliott,et al.  Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. , 2005, Journal of pharmaceutical sciences.

[31]  L. Comeau,et al.  Role of endogenous IL‐10 in LPS‐induced STAT3 activation and IL‐1 receptor antagonist gene expression , 2004, Journal of leukocyte biology.

[32]  F. Schmidt,et al.  Recombinant expression systems in the pharmaceutical industry , 2004, Applied Microbiology and Biotechnology.

[33]  P. Constantinides,et al.  Advances in lipid-based drug solubilization and targeting , 2004 .

[34]  Gorka Orive,et al.  Drug delivery in biotechnology: present and future. , 2003, Current opinion in biotechnology.

[35]  G. Gregoriadis,et al.  Polysialylated insulin: synthesis, characterization and biological activity in vivo. , 2003, Biochimica et biophysica acta.

[36]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[37]  M. Goalstone,et al.  Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. , 2001, The Journal of biological chemistry.

[38]  V. Mauro,et al.  A 5′ Leader of Rbm3, a Cold Stress-induced mRNA, Mediates Internal Initiation of Translation with Increased Efficiency under Conditions of Mild Hypothermia* , 2001, The Journal of Biological Chemistry.

[39]  T. Yoshikawa,et al.  A novel and simple type of liposome carrier for recombinant interleukin‐2 , 2001, The Journal of pharmacy and pharmacology.

[40]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Y. Oh,et al.  Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. , 1999, International journal of pharmaceutics.

[42]  W. Berthold,et al.  Polyethylene glycol-conjugated pharmaceutical proteins , 1998 .

[43]  E. Keystone,et al.  IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. , 1998, Rheumatic diseases clinics of North America.

[44]  A. Shahzamani,et al.  A month–long effect from a single injection of microencapsulated human growth hormone , 1996, Nature Medicine.

[45]  Y. Aragane,et al.  In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. , 1994, The Journal of investigative dermatology.